Our Story
Since our inception in 2015 in Denmark, Liva has been leading the way in the field of digital therapeutics. Our ambition is to prevent, manage and treat chronic disease through behaviour and lifestyle change, with a keen focus on cardiometabolic conditions. Over the years, we have expanded our reach across national healthcare systems and geographies, marking our presence as a global force for advancing health outcomes.
We integrate seamlessly into healthcare systems offering a unique hybrid digital therapeutics platform that combines personalised, one-on-one lifestyle coaching with innovative digital-first delivery.
Our team of dedicated healthcare professionals create tailored behaviour and lifestyle change programs to support patients in their journey to prevent, manage and treat obesity, type 2 diabetes, pre-diabetes and other cardiometabolic conditions. The safety and efficacy of our digital therapeutic programmes are well-supported by extensive evidence from randomised controlled trials (RCTs) and other clinical studies.
Headquartered in Copenhagen and London, Liva is at the forefront of delivering industry-leading lifestyle change and chronic disease management programmes across Europe. Our collaborations with healthcare systems, including the NHS, as well as partnerships with some of the world’s largest life science companies and health insurers allow us to impact lives on a large scale.
Executive Management

Shahram Sharif
CEO

Martin Paarse
COO & Deputy CEO

Karen O'Regan
CCO & UK GM

Sian Jarvis
CMO
Founders & Board of Directors

Rune Bech
Co-Founder

Carl Brandt
Co-Founder, Medical Director

Boris Bernstein
MIG, Munich

Guido Hegener
DHV, Berlin

Søren Hein
MIG, Munich

Joachim Vanggaard
Maj Invest, Copenhagen
Latest news

Liva Healthcare appoints the new Chair of the Board
Liva is delighted to introduce Michel Lussier as the new Chair of the Board as the business gears up to accelerate expansion to new markets. LONDON, United Kingdom and COPENHAGEN, Denmark, August 30, 2023 Liva Healthcare has announced that it

Liva Healthcare selected by NICE to Offer Hybrid Weight-Loss Programmes on the NHS
LONDON, United Kingdom, August 16, 2023 Liva is delighted to be provisionally selected as one of the leading digital therapeutics platforms to offer hybrid weight-loss

Liva Healthcare appoints new CMO and CCO & UK GM
LONDON, United Kingdom, 28 July, 2023 Liva is pleased to welcome two new industry leaders, Sian Jarvis and Karen O’Regan, to its executive team. These

Breakthrough RCT study shows efficacy of the Liva programme in producing sustained weight loss
A new study led by the Department of Public Health at the University of Southern Denmark and Liva Healthcare found that digital health coaching is